EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Outcomes for Patients With Primary Gastrointestinal Follicular Lymphoma: Results From a Multicenter Analysis

Frederique St-Pierre iD, Ruohui Chen iD, Xinlei Mi, Taha Alrifai, Khaled Alhamad, Brittany McCall, Kaitlin Annunzio, Peter G Doukas, Alexa Schoen, Lucy Fu, Cherry Au, Natalie Otto und 15 weitere

Cancer Medicine · 2026-11 · 15 (11)

DOI: 10.1002/cam4.72472 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Medicine, online erschienen am 11.11.2026. Verfasst von Frederique St-Pierre und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois…. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Gastrointestinal Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Robert H. Lurie Comprehensive Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gastrointestinal (GI) follicular lymphoma (FL) is a rare disease, accounting for less than 5% of GI non‐Hodgkin's lymphomas (NHL). We conducted a multi‐institutional study to clarify baseline features, common practices, and survival outcomes in primary GI FL.

Methods

We performed a retrospective analysis of patients with primary GI FL from 8 North American institutions. Progression‐free survival (PFS), overall survival (OS), and progression of disease at 24 months (POD24) were assessed.

Results

Two hundred and two patients were included in the analysis. Median follow up was 5.6 years. Median age at diagnosis was 60 years (range: 51–68) with a 1:1 male to female ratio. For those observed, median time to first treatment was 4.5 years. For those treated, overall response rate was 93% ( n = 112) and median time to second‐line treatment was 3.9 years. Patients who were initially observed had similar OS to those who were treated up‐front. Age ≥ 60, histologic Grade 3A, and hemoglobin < 12 g/dL at diagnosis were independent predictors of inferior survival. Based on these results, we created the GI‐FLIPI score, a prognostic index using these three readily available clinical factors to help predict outcomes in patients with GI FL. Median OS was significantly shorter in the high‐risk group compared to intermediate‐ and low‐risk groups, with a c‐index of 0.767.

Conclusions

This multi‐institutional analysis describes characteristics of a large cohort of patients with GI FL. The GI‐FLIPI score shows promise with high prediction accuracy and may help guide management in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, FollicularGastrointestinal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleRetrospective StudiesAgedMiddle AgedTreatment OutcomePrognosisProgression-Free Survival

Stichwörter der Autor:innen

extranodal lymphomafollicular lymphomagastrointestinal lymphomanon‐Hodgkin's lymphoma

Autor:innen und Institutionen

  • Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Department of Preventative Medicine-Biostatistics, Feinberg School of Medicine Northwestern University, Chicago, Illinois, USA.
  • Division of Hematology/Oncology/Cellular Therapy, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
  • Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
  • Division of Hematology-Oncology, Rhode Island Hospital, Providence, Rhode Island, USA.
  • Division of Hematology, Department of Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.

ORCID-Profile: Frederique St-Pierre, Ruohui Chen, Alexandra Rojek, Yangruijue Ma, Matthew J Matasar, Narendranath Epperla, Thomas A Ollila, Lindsey Fitzgerald, Alexey V Danilov, Geoffrey Shouse, Asaad Trabolsi, Juan P Alderuccio, Izidore S Lossos, Seo-Hyun Kim, Reem Karmali

Förderung

  • Robert H. Lurie Comprehensive Cancer Center

Zitieren

APA

St-Pierre, F., Chen, R., Mi, X., Alrifai, T., Alhamad, K., McCall, B., Annunzio, K., Doukas, P. G., Schoen, A., Fu, L., Au, C., Otto, N., Rojek, A., Ma, Y., Kline, J., Cohen, J. B., Matasar, M. J., Epperla, N., Ollila, T. A., …, & Karmali, R. (2026). Outcomes for Patients With Primary Gastrointestinal Follicular Lymphoma: Results From a Multicenter Analysis. Cancer Medicine, 15(11). https://doi.org/10.1002/cam4.72472

Vancouver

St-Pierre F, Chen R, Mi X, Alrifai T, Alhamad K, McCall B, et al. Outcomes for Patients With Primary Gastrointestinal Follicular Lymphoma: Results From a Multicenter Analysis. Cancer Medicine. 2026;15(11). doi:10.1002/cam4.72472

BibTeX
@article{StPierre2026,
  author = {St-Pierre, Frederique and Chen, Ruohui and Mi, Xinlei and Alrifai, Taha and Alhamad, Khaled and McCall, Brittany and Annunzio, Kaitlin and Doukas, Peter G and Schoen, Alexa and Fu, Lucy and Au, Cherry and Otto, Natalie and Rojek, Alexandra and Ma, Yangruijue and Kline, Justin and Cohen, Jonathon B and Matasar, Matthew J and Epperla, Narendranath and Ollila, Thomas A and Fitzgerald, Lindsey and Danilov, Alexey V and Shouse, Geoffrey and Trabolsi, Asaad and Alderuccio, Juan P and Lossos, Izidore S and Kim, Seo-Hyun and Karmali, Reem},
  title = {Outcomes for Patients With Primary Gastrointestinal Follicular Lymphoma: Results From a Multicenter Analysis},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1002/cam4.72472}
}
Kostenlos starten →